1-1049467-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198576.4(AGRN):​c.4514+16G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.017 in 1,600,510 control chromosomes in the GnomAD database, including 1,445 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.059 ( 732 hom., cov: 32)
Exomes 𝑓: 0.013 ( 713 hom. )

Consequence

AGRN
NM_198576.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.863

Publications

3 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-1049467-G-C is Benign according to our data. Variant chr1-1049467-G-C is described in ClinVar as [Benign]. Clinvar id is 263186.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.4514+16G>C intron_variant Intron 25 of 35 ENST00000379370.7 NP_940978.2 O00468-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.4514+16G>C intron_variant Intron 25 of 35 1 NM_198576.4 ENSP00000368678.2 O00468-6

Frequencies

GnomAD3 genomes
AF:
0.0592
AC:
8999
AN:
152058
Hom.:
728
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.188
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0281
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00921
Gnomad OTH
AF:
0.0507
GnomAD2 exomes
AF:
0.0203
AC:
4813
AN:
236558
AF XY:
0.0162
show subpopulations
Gnomad AFR exome
AF:
0.194
Gnomad AMR exome
AF:
0.0154
Gnomad ASJ exome
AF:
0.00494
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00126
Gnomad NFE exome
AF:
0.00944
Gnomad OTH exome
AF:
0.0150
GnomAD4 exome
AF:
0.0125
AC:
18123
AN:
1448334
Hom.:
713
Cov.:
43
AF XY:
0.0118
AC XY:
8532
AN XY:
721038
show subpopulations
African (AFR)
AF:
0.195
AC:
6533
AN:
33454
American (AMR)
AF:
0.0171
AC:
762
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.00529
AC:
138
AN:
26102
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39670
South Asian (SAS)
AF:
0.00410
AC:
353
AN:
86130
European-Finnish (FIN)
AF:
0.00142
AC:
58
AN:
40800
Middle Eastern (MID)
AF:
0.0343
AC:
198
AN:
5766
European-Non Finnish (NFE)
AF:
0.00797
AC:
8858
AN:
1111530
Other (OTH)
AF:
0.0203
AC:
1223
AN:
60234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1073
2146
3218
4291
5364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0594
AC:
9041
AN:
152176
Hom.:
732
Cov.:
32
AF XY:
0.0570
AC XY:
4242
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.188
AC:
7811
AN:
41486
American (AMR)
AF:
0.0280
AC:
428
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00663
AC:
32
AN:
4826
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10624
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00921
AC:
626
AN:
67990
Other (OTH)
AF:
0.0502
AC:
106
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
403
806
1209
1612
2015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00242
Hom.:
1
Bravo
AF:
0.0683
Asia WGS
AF:
0.0160
AC:
56
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 20, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
7.3
DANN
Benign
0.29
PhyloP100
0.86
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112917612; hg19: chr1-984847; COSMIC: COSV65070069; COSMIC: COSV65070069; API